Rubiayannone A

CAS No. 517918-25-1

Rubiayannone A( ——— )

Catalog No. M38310 CAS No. 517918-25-1

Rubiayannone A is an anthraquinone glycoside with an antiplatelet aggregation activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG 1408 Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Rubiayannone A
  • Note
    Research use only, not for human use.
  • Brief Description
    Rubiayannone A is an anthraquinone glycoside with an antiplatelet aggregation activity.
  • Description
    Rubiayannone A is an anthraquinone glycoside with an antiplatelet aggregation activity.
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    517918-25-1
  • Formula Weight
    550.469
  • Molecular Formula
    C25H26O14
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Meei-Jen Liou, et al. Constituents from Rubia Ustulata Diels and R. Yunnanensis Diels and Their Antiplatelet Aggregation Activity. Journal of the Chinese Chemical Society, 24 September 2013.
molnova catalog
related products
  • Safflower-yellow

    Safflower yellow is extracted from the flowers of the plant safflower (Carthamus tinctorius) and as the traditional Chinese medicine it has been extensively used for the treatment of cardio cerebrovascular diseases.

  • 25-Epi-28-epi-cyaste...

    25-Epi-28-epi-cyasterone (3) is a stereoisomer of cyasterone that can be isolated from Cyathula officinalis.

  • Pimonidazole hydroch...

    Pimonidazole hydrochloride accumulates in hypoxic cells via covalent binding with macromolecules or by forming reductive metabolites after the reduction of its nitro group.